22 March 2016 - The TGA has been closely monitoring reports of adverse events following immunisation with Bexsero meningococcal B vaccine, specifically those relating to fever in infants and children. Fever is a potential risk factor for the development of a seizure.

These monitoring activities have found no new or unexpected safety issues.

From 1 March 2014 to 17 December 2015 there have been 44 reports of fever in patients of all ages following immunisation with Bexsero. During the same time period, there have been two reports of febrile seizures. Other adverse events reported included generalised allergic reaction (18), injection site reaction (48), pain in the vaccinated limb (23) and Kawasaki disease (1).

For more details, go to: http://www.tga.gov.au/monitoring-communication/bexsero-meningococcal-b-vaccine